Twist Bioscience Corporat...

NASDAQ: TWST · Real-Time Price · USD
28.47
-0.37 (-1.28%)
At close: Aug 15, 2025, 1:13 PM

Twist Bioscience Balance Sheet Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
Cash & Equivalents
226.32M 286.47M 378.69M 465.83M
Short-Term Investments
50.08M 49.94M 126.28M 12.03M
Long-Term Investments
n/a n/a 1.57M 1.53M
Other Long-Term Assets
5.91M 8.49M 4.96M 9.2M
Receivables
34.9M 44.06M 40.29M 28.55M
Inventory
24.08M 32.06M 39.31M 31.8M
Other Current Assets
11.4M 11.72M 11.91M 8.28M
Total Current Assets
346.78M 424.26M 596.48M 546.5M
Property-Plant & Equipment
161.35M 203.36M 214.39M 105.7M
Goodwill & Intangibles
100.29M 140.29M 145.55M 40.7M
Total Long-Term Assets
267.55M 352.15M 364.89M 155.6M
Total Assets
614.32M 776.4M 961.38M 702.1M
Account Payables
1.63M 14.05M 20.09M 14.9M
Deferred Revenue
2.13M n/a 3.48M 28.76M
Short-Term Debt
n/a n/a 13.64M 9.77M
Other Current Liabilities
22.53M 18.56M 29.64M 23.74M
Total Current Liabilities
71.01M 73.32M 90.66M 63.05M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
407K 475K 60K 5.07M
Total Long-Term Liabilities
70.63M 79.65M 81.33M 58.22M
Total Liabilities
141.63M 152.97M 171.99M 121.28M
Total Debt
85.03M 94.07M 94.91M 62.92M
Common Stock
n/a n/a n/a n/a
Retained Earnings
-1.24B -1.03B -828.42M -610.55M
Comprehensive Income
-522K -756K -1.84M 546K
Shareholders Equity
472.69M 623.43M 789.38M 580.82M
Total Investments
50.08M 49.94M 126.28M 12.03M